Core Viewpoint - The company is focused on the ecological layout in the pharmaceutical and health industry, with its main business covering pharmaceutical distribution, digital empowerment, and health services [1] Summary by Categories Business Focus - The company will concentrate on its core strategy and continue to deepen its layout across the entire pharmaceutical health industry chain [1] Current Collaborations - As of now, the company has no business cooperation arrangements with military enterprises [1]

Group 1 - China National Fisheries announced that its shareholder, China State-Owned Enterprises Mixed Ownership Reform Fund Co., Ltd., reduced its stake from 5.7076% to 5% by selling 2.5888 million shares at an average price of 10.31 yuan per share [1] - China National Fisheries, established in April 1998, focuses on deep-sea fishing, seafood processing and trade, and marine fishery services [2] Group 2 - Guilin Tourism plans to publicly select a partner for the "Living Lotus" project to build a theater and related facilities, with the partner responsible for investment, construction, and operation [2] - Guilin Tourism, founded in April 1998, operates in boat passenger transport, scenic tourism, hotels, and road passenger transport [2] Group 3 - Zhaomin Technology intends to issue convertible bonds to raise no more than 590 million yuan for new projects related to automotive components and precision engineering plastics [3] - Zhaomin Technology, established in October 2011, specializes in the R&D, production, and sales of precision injection parts and molds [3] Group 4 - Zhaomin Technology plans to establish overseas subsidiaries in Singapore and Thailand, focusing on wholesale trade and technology development in automotive precision components [4] - The registered capital for the Singapore subsidiaries is set at 1,000 USD, while the Thai subsidiary will have a capital of 500,000 THB [4] Group 5 - Yiyigou's subsidiary plans to increase capital by 8 million yuan to an associated company, with a pre-investment valuation of 42 million yuan [5] - Yiyigou, founded in April 2007, provides full-channel pharmaceutical distribution services [6] Group 6 - Yunda Express reported a 0.88% year-on-year decline in October express service revenue, totaling 4.495 billion yuan, with a business volume decrease of 5.11% [7] - Yunda Express, established in April 1996, operates in comprehensive express logistics [8] Group 7 - SAIWO Technology announced the first batch delivery of light transfer films for perovskite tandem components, marking a significant step in commercial application [8] - The current delivery is small-scale and will not significantly impact the company's revenue in 2024 [8] Group 8 - Hunan Baiyin's shareholder plans to reduce its stake by up to 1.95%, equating to a maximum of 55 million shares [9] - Hunan Baiyin, founded in November 2004, specializes in the smelting and sales of precious metals [9] Group 9 - Ningbo Construction's acquisition of Ningbo Transportation Engineering Construction Group has been approved by the Shanghai Stock Exchange [10] - Ningbo Construction, established in December 2004, focuses on construction engineering and related services [10] Group 10 - Sudar's shareholder plans to reduce its stake by up to 3%, which amounts to a maximum of 2.28 million shares [11] - Sudar, founded in July 2009, provides aftermarket services for hydraulic supports in coal mining machinery [12] Group 11 - Aeston plans to establish a joint venture with BOE Technology Group, focusing on the development and sales of drive technology products [13] - Aeston, established in February 2002, specializes in automation core components and industrial robotics [13] Group 12 - CICC is planning to absorb and merge Dongxing Securities and Xinda Securities through a stock exchange, with trading suspended for up to 25 days [14] - CICC, founded in July 1995, provides investment banking and asset management services [14] Group 13 - Dongjie Intelligent plans to purchase robots from an associated company for a total of 24.325 million yuan [15] - Dongjie Intelligent, established in December 1995, focuses on intelligent production systems and logistics [15] Group 14 - Shentong Express reported an 11.84% year-on-year increase in October express service revenue, totaling 4.95 billion yuan [16] - Shentong Express, founded in November 2001, operates in the express service industry [17] Group 15 - Zhongfu Industrial plans to invest 259 million yuan in a project to produce 3 million aluminum wheels [18] - Zhongfu Industrial, established in January 1997, specializes in aluminum processing and related industries [18] Group 16 - Maoshuo Power's director plans to reduce his stake by up to 980,300 shares, representing 0.2749% of the total shares [19] - Maoshuo Power, founded in March 2006, focuses on the R&D and production of power supplies [19] Group 17 - Wentai Technology's control over Anshi Semiconductor remains limited despite the lifting of an asset freeze order [20] - Wentai Technology, established in January 1993, specializes in mobile communication and semiconductor technology [20] Group 18 - Zhongyida's actual controller is involved in the merger of Xinda Securities by CICC, with no impact on Zhongyida's equity structure [20] - Zhongyida, founded in June 1992, produces and sells fine chemical products [20] Group 19 - Jinlongyu's subsidiary received a criminal judgment for contract fraud, with penalties imposed on both the company and an individual [20] - Jinlongyu, established in June 2005, focuses on kitchen food and oil products [20]

Market Overview - The pharmaceutical commercial sector experienced a decline of 0.51% on November 20, with Renmin Tongtai leading the drop [1] - The Shanghai Composite Index closed at 3931.05, down 0.4%, while the Shenzhen Component Index closed at 12980.82, down 0.76% [1] Stock Performance - Notable gainers included: - HeFu China (603122) with a closing price of 26.18, up 10.00% [1] - KaiKai Industry (600272) at 14.58, up 4.14% [1] - Zhejiang Zhenyuan (000705) at 9.91, up 1.64% [1] - Major decliners included: - Renmin Tongtai (600829) at 14.36, down 9.97% [2] - Jianfa Zhixin (301584) at 32.34, down 4.88% [2] - Shuyupingmin (301017) at 13.40, down 3.11% [2] Capital Flow - The pharmaceutical commercial sector saw a net outflow of 260 million yuan from institutional investors, while retail investors had a net inflow of 264 million yuan [2] - The overall capital flow indicates a shift in investor sentiment, with retail investors showing more interest in the sector [2] Individual Stock Capital Flow - Shanghai Pharmaceuticals (601607) had a net inflow of 36.98 million yuan from institutional investors, but a net outflow from retail investors [3] - KaiKai Industry (600272) also saw a net inflow from institutional investors of 27.76 million yuan, with retail investors showing a net outflow [3] - Other stocks like Zhejiang Zhenyuan (000705) and Dajia Weikang (301126) experienced mixed capital flows, indicating varied investor interest [3]

根据公告，本次增资协议中，神鸟尚医云设定了明确的经营目标，即需于2025年12月31日前在四川省内 建成18个中心药房，并实现在线签约医生数量突破2500人；于2026年12月31日前新开拓重庆、贵州、安 徽、江苏四个区域市场，在线签约医生再增3000人。神鸟尚医云将通过"AI云开方"和"智慧中心药房"打 造的医疗第三方终端共享平台，为基层医疗机构提供集医生分级诊疗、远程诊疗、智能调剂、药品代煎 （膏、丹、丸、散、水剂）及配送于一体的一站式解决方案。 药易购表示，本次对神鸟尚医云的战略增资，是公司产业布局的重要一环。公司以全局战略业务发展角 度进行投资，可以有效发挥公司在医药供应链、医药物流配送等方面的资源积累，进一步助力和赋能神 鸟尚医云发展，并利用神鸟尚医云链接的诊所、医生、销售推广资源推动公司供应链业务发展。同时， 四川天府数智参与投资，可以有效发挥其链接的高等级医生、专家资源的优势，向神鸟尚医云导入更多 优质的经典名方、院内制剂等供应链资源。通过本次增资，公司在业务及战略发展上进一步围绕医药行 业多元化发展进行纵深布局，为公司战略目标的实现和持续长远的发展发挥积极作用。 中证报中证网讯（王珞）11月1 ...

（文章来源：证券日报） 资料显示，神鸟尚医云成立于2024年，专注于通过"AI云开方"与"AI智慧中心药房"的联动，成功打造了 医疗第三方终端共享平台，为基层医疗机构提供集医生分级诊疗、远程诊疗、智能调剂、药品代煎 （膏、丹、丸、散、水剂）及配送于一体的一站式解决方案，可显著降低基层医疗机构供应链管理负 担，助力其提升服务能力与运营效率，提升基层医疗资源的可获得性等。 公告显示，此次对神鸟尚医云的战略增资，是药易购产业布局的重要一环。公司将利用神鸟尚医云链接 的诊所、医生、销售推广资源推动公司供应链业务发展。 本报讯 （记者蒙婷婷）11月19日晚间，四川合纵药易购医药股份有限公司（以下简称"药易购"）发布 公告称，其全资子公司四川药易购科技集团有限公司与控股子公司四川天府数智文化传媒有限公司，拟 合计使用800万元自有资金，向四川神鸟尚医云科技有限公司（以下简称"神鸟尚医云"）进行增资，旨 在纵深公司在医药行业多元化发展的布局。 ...

格隆汇11月19日丨药易购(300937.SZ)公布，公司全资子公司四川药易购科技集团有限公司（简称"药易 购科技集团"）、公司控股子公司四川天府数智文化传媒有限公司（简称"四川天府数智"）拟使用自有 资金向神鸟尚医云增资共800万元（其中，药易购科技集团增资600万元、四川天府数智增资200万 元），标的公司投前估值为4,200万元。待本次增资完成后，标的公司的注册资本将由100万元增至 119.0476万元，药易购科技集团持股比例由10.00%增至20.40%，四川天府数智持股比例为4.00%。 ...

Group 1 - The core point of the article is that Yaoyigou (SZ 300937) announced the convening of its fourth board meeting on November 18, 2025, to discuss a capital increase for its subsidiary and related transactions [1] - For the first half of 2025, the revenue composition of Yaoyigou is as follows: pharmaceutical distribution (contract distribution + market comparison) accounts for 47.09%, pharmaceutical sales (direct procurement) accounts for 41.92%, pharmaceutical manufacturing and OEM business accounts for 8.55%, and other businesses account for 2.44% [1] - As of the report date, Yaoyigou has a market capitalization of 3.1 billion yuan [1]

经与会董事审议，以投票表决方式审议了以下议案： 1、审议通过《关于子公司向四川神鸟尚医云科技有限公司增资暨关联交易 及增加日常关联交易预计的议案》 与会董事同意公司全资子公司四川药易购科技集团有限公司（以下简称"药 易购科技集团"）、公司控股子公司四川天府数智文化传媒有限公司（以下简称 "四川天府数智"）对四川神鸟尚医云科技有限公司（以下简称"神鸟尚医云"） 按照投前估值 4,200 万元（以下万元均指人民币万元）增资共 800 万元；其中， 药易购科技集团增资 600 万元，四川天府数智增资 200 万元。本次增资完成后， 神鸟尚医云的注册资本由 100 万元增加至 119.0476 万元，药易购科技集团持股 比例由 10%增加至 20.40%，四川天府数智持股比例为 4.00%。 证券代码：300937 证券简称：药易购 公告编号：2025-049 四川合纵药易购医药股份有限公司 第四届董事会第四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 四川合纵药易购医药股份有限公司（以下简称"公司"）第四届董事会第四 次会议 ...

证券代码：300937 证券简称：药易购 公告编号：2025-050 暨关联交易及增加日常关联交易预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、关联交易概述 根据《深圳证券交易所创业板股票上市规则》《企业会计准则第 36 号—— 关联方披露》等相关规定，四川神鸟尚医云科技有限公司（以下简称"神鸟尚医 云""标的公司"）为公司董事长、总经理陈顺军先生的关联方，本次增资事项、 公司及控股子公司根据实际经营情况预计未来可能与神鸟尚医云发生业务往来， 构成关联交易。 四川合纵药易购医药股份有限公司 （一）增资暨关联交易的情况 关于子公司向四川神鸟尚医云科技有限公司增资 四川合纵药易购医药股份有限公司（以下简称"公司"）全资子公司四川药 易购科技集团有限公司（以下简称"药易购科技集团"）、公司控股子公司四川 天府数智文化传媒有限公司（以下简称"四川天府数智"）拟使用自有资金向神 鸟尚医云增资共 800 万元（其中，药易购科技集团增资 600 万元、四川天府数智 增资 200 万元），标的公司投前估值为 4,200 万元。 待本次增资完成后，标的公司的注 ...

证券日报网讯药易购（300937）11月19日在互动平台回答投资者提问时表示，随着冬季呼吸道疾病进入 高发期，公司密切关注医药市场动态，积极发挥医药流通企业的供应链优势，基于公司的药品稳定供应 与保障体系建设并结合市场需求的波动情况，动态调整药品各类库存，致力于保障终端药品的稳定供 应。 ...